Tomer Hertz
- Staff Scientist
- Vaccine and Infectious Disease Division
- Staff Scientist
- Public Health Sciences Division
Education
The Hebrew University of Jerusalem, 2007, PhD (Computational Neuroscience)
The Hebrew University of Jerusalem, 1999, BS (Computer Science and an Interdisciplinary Program in the Humanities)
Research Interests
- Host-pathogen co-evolution
- T-cell and B-cell immunodominance and the effects of immunological history
- Computational immunology focusing on human leukocyte antigen (HLA) binding prediction and its applications in vaccine design, HLA-viral interactions, and immunodominance
Current Projects
- Co-evolution of viruses and immune system
- Capturing Immunological History using Antigen Microarrays
- Computational Approaches to Studying Immunodominance
- Analysis of T-cell responses in HIV vaccine clinical trials
- Sieve analysis of breakthrough sequences in HIV vaccine trials
- Adjuvant effects on immunodominance patterns in vaccine trials
- Correlates of protection in HIV and influenza vaccines
- Identifying host specificity determinants in influenza viruses
Related News
- Diseases
& Research
- Treatment
& Support
- About Us
- Labs &
Projects
- Events &
Community Programs
- How You
Can Help Us
The Hutchinson Center's world-renowned scientists are discovering new ways to detect, prevent and treat cancer, HIV/AIDS and many other diseases.
- License Our Discoveries
The Hutchinson Center's world-renowned researchers work together to pursue lifesaving therapies that will help eliminate cancer and related diseases.
The Hutchinson Center's clinical research breakthroughs are delivered to patients through our treatment arm, the Seattle Cancer Care Alliance. This collaboration combines the strengths of the Hutchinson Center, UW Medicine and Seattle Children's.
You can help eliminate cancer and related diseases by attending Hutchinson Center events and participating in our other fundraising and community efforts.
- Divisions
The Hutchinson Center's pioneering researchers push the boundaries of science to find new ways to prevent, detect and treat cancer and related diseases.
Private support is critical to fund new research ideas and innovations, accelerating our ability to make lifesaving discoveries.
